Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Clinical significance of connective tissue growth factor in hepatitis B virus-induced hepatic fibrosis.

Piao RL, Brigstock DR, Zhu J, Zhang ML, Gao RP.

World J Gastroenterol. 2012 May 14;18(18):2280-6. doi: 10.3748/wjg.v18.i18.2280.

2.

Correlation of Connective Tissue Growth Factor (CTGF/CCN2) with Hepatic Fibrosis in Chronic Hepatitis B.

Ferdoushi S, Paul D, Ghosh CK, Sultana T, Joarder AI, Islam MS, Islam MS, Mahmuduzzaman M, Rahman Q, Ahmed AN.

Mymensingh Med J. 2015 Jul;24(3):558-63.

PMID:
26329955
3.

Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.

Gressner OA, Fang M, Li H, Lu LG, Gressner AM, Gao CF.

Clin Chim Acta. 2013 Jun 5;421:126-31. doi: 10.1016/j.cca.2013.02.029. Epub 2013 Mar 15.

PMID:
23501329
4.

The level of connective tissue growth factor in sera of patients with hepatitis B virus strongly correlates with stage of hepatic fibrosis.

Guo-Qiu W, Nai-Feng L, Xiao-Bo V, Linxian L, Chen Z, Lixia G, Zhao L.

Viral Immunol. 2010 Feb;23(1):71-8. doi: 10.1089/vim.2009.0067.

PMID:
20121404
5.

Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.

Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, Janetzko A, Wiederholt T, Berg T, Müller T, Trautwein C, Gressner AM, Weiskirchen R.

J Viral Hepat. 2009 Sep;16(9):612-20. doi: 10.1111/j.1365-2893.2009.01110.x. Epub 2009 Feb 20.

PMID:
19243500
6.

APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.

Ucar F, Sezer S, Ginis Z, Ozturk G, Albayrak A, Basar O, Ekiz F, Coban S, Yuksel O, Armutcu F, Akbal E.

Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1076-81. doi: 10.1097/MEG.0b013e32835fd699.

PMID:
23510962
8.

Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.

Liu XD, Wu JL, Liang J, Zhang T, Sheng QS.

World J Gastroenterol. 2012 Jun 14;18(22):2784-92. doi: 10.3748/wjg.v18.i22.2784.

9.
10.

The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis.

Zhang D, Wang NY, Yang CB, Fang GX, Liu W, Wen J, Luo C.

Dig Dis Sci. 2010 Mar;55(3):767-74. doi: 10.1007/s10620-009-0781-9. Epub 2009 Mar 18.

PMID:
19294506
11.

Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.

Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, Oncul O, Gorenek L.

Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1320-4. doi: 10.1097/MEG.0000000000000203.

PMID:
25210777
12.

Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.

Du WJ, Zhen JH, Zeng ZQ, Zheng ZM, Xu Y, Qin LY, Chen SJ.

Diagn Pathol. 2013 Feb 28;8:40. doi: 10.1186/1746-1596-8-40.

13.

Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.

Xiu M, Liu YH, Brigstock DR, He FH, Zhang RJ, Gao RP.

World J Gastroenterol. 2012 Dec 21;18(47):7070-8. doi: 10.3748/wjg.v18.i47.7070.

14.

Expression of heat shock protein 47, transforming growth factor-beta 1, and connective tissue growth factor in liver tissue of patients with Schistosoma japonicum-induced hepatic fibrosis.

Li L, Wu T, Huang J, Ma K, Xu L, Wang H, Fan X, Tao R, Ai G, Ning Q.

Parasitology. 2015 Feb;142(2):341-51. doi: 10.1017/S0031182014001115. Epub 2014 Aug 11.

PMID:
25111595
15.

Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B.

Ma LN, Liu XY, Luo X, Hu YC, Liu SW, Tang YY, Pan JL, Ding XC.

Hepatogastroenterology. 2015 Mar-Apr;62(138):368-72.

PMID:
25916065
16.

Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.

Fung J, Lai CL, Chan SC, But D, Seto WK, Cheng C, Wong DK, Lo CM, Fan ST, Yuen MF.

Am J Gastroenterol. 2010 May;105(5):1116-22. doi: 10.1038/ajg.2009.665. Epub 2009 Nov 17.

PMID:
19920809
17.

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.

J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5.

PMID:
19200132
18.

Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B.

Purnak T, Beyazit Y, Oztas E, Yesil Y, Efe C, Torun S, Celik T, Tenlik I, Kurt M, Ozaslan E.

J Renin Angiotensin Aldosterone Syst. 2012 Jun;13(2):244-9. doi: 10.1177/1470320311434241. Epub 2012 Jan 25.

PMID:
22277254
19.

Serum WFA+ -M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection.

Zou X, Zhu MY, Yu DM, Li W, Zhang DH, Lu FJ, Gong QM, Liu F, Jiang JH, Zheng MH, Kuno A, Narimatsu H, Zhang Y, Zhang XX.

Liver Int. 2017 Jan;37(1):35-44. doi: 10.1111/liv.13188. Epub 2016 Jul 12.

PMID:
27300763
20.

Quantitative fibrosis estimation by image analysis predicts development of decompensation, composite events and defines event-free survival in chronic hepatitis B patients.

Bihari C, Rastogi A, Sen B, Bhadoria AS, Maiwall R, Sarin SK.

Hum Pathol. 2016 Sep;55:63-71. doi: 10.1016/j.humpath.2016.04.012. Epub 2016 May 14.

PMID:
27189343

Supplemental Content

Support Center